2-(4-Bromophenyl)-6-methyl-1,3,6,2-dioxazaborocane, 97%, 250mg

Dimethyl trans-1,2-cyclopropanedicarboxylate, 95, 25g

Methyl 2-hydroxy-3-isopropylbenzoate, 98%, 5g

(R)-1-(2-Fluoro-4-methylphenyl)ethanamine hydrochloride, 5g

Nonanophenone>97.0%(GC)25mL

3-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpropanoic acid, 95.0%, 1g

1-ethyl-N-methyl-4-piperidinamine, 95.0%, 250mg

2-methylthieno[2,3-d]pyrimidin-4(3H)-one hydrochloride, 95.0%, 250mg

Ethyl 3-(2-(benzyloxy)phenyl)oxirane-2-carboxylate, 98%, 100mg

3-(1-Methyl-1H-imidazol-5-yl)benzoic acid, 95.0%, 5g

1-[6-(Trifluoromethyl)pyridin-3-yl]ethanone, 97.0%, 1g

Récipient à col large ROTILABO® PETG, 2000 ml, 4 Pièce(s)

8-Methoxyquinoline-6-carboxylic acid, 98%, 1g